Eevia Health Plc receiveS A 757 Ksek (66 KEUR) sales order for Feno-Sambucus™ 7 Organic

Eevia Health ("Eevia" or "The Company") received a 757 kSEK / 66 kEUR sales order for the elderberry extract Feno-Sambucus™ 7 ORGANIC from a distributor in the US.

The order is from Select Ingredients, a distributor located in San Diego, California, US. Select Ingredients is a specialist in organic ingredients and high-quality natural plant extracts, serving branded customers in the Golden State and other large states in the US.

There are two end customers behind this order. The first is a brand owner that specializes in organic plant-based food supplements without sugars and artificial compounds. The end customer provides supplements skews for the whole family. The order end customer is a company in the whole foods and drinks segments, which is experiencing very fast growth across North America.

This is a repeat order from one of the end customers and a start order from the other. Eevia expects further repeat orders in the future.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: [email protected]                      

Telephone: +358 400 22 5967   


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]